AMGN Stock Analysis: AMGEN Inc
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples in
- Latest close
- $421.51
- 20-day change
- -3.79%
- Trend state
- LEAN BULL
- Classification
- Healthcare · Drug Manufacturers - General
Market context
AMGEN Inc moved -3.79% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BULL.
Latest report
The latest cached company filing period (FY2025 · $36.8B revenue · $7.7B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Profitability is currently the strongest dimension at 5.4/6, while Health is the lowest at 2.2/6. Scores are comparative research signals, not forecasts.